FATE THERAPEUTICS INC Insider Trading for January 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in FATE THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in FATE THERAPEUTICS INC for January 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 21 2021 | FATE | FATE THERAPEUTICS ... | TAHL CINDY | General Counsel and ... | Option Exercise | M | 2.90 | 35,000 | 101,500 | 28,149 | |
| Jan 21 2021 | FATE | FATE THERAPEUTICS ... | TAHL CINDY | General Counsel and ... | Sell | S | 117.07 | 200 | 23,413 | 90,035 | 90.2 K to 90 K (-0.22 %) |
| Jan 21 2021 | FATE | FATE THERAPEUTICS ... | TAHL CINDY | General Counsel and ... | Sell | S | 115.97 | 4,021 | 466,333 | 90,235 | 94.3 K to 90.2 K (-4.27 %) |
| Jan 21 2021 | FATE | FATE THERAPEUTICS ... | TAHL CINDY | General Counsel and ... | Sell | S | 115.09 | 14,944 | 1,719,935 | 94,256 | 109.2 K to 94.3 K (-13.68 %) |
| Jan 21 2021 | FATE | FATE THERAPEUTICS ... | TAHL CINDY | General Counsel and ... | Sell | S | 114.11 | 15,835 | 1,806,959 | 109,200 | 125 K to 109.2 K (-12.66 %) |
| Jan 21 2021 | FATE | FATE THERAPEUTICS ... | TAHL CINDY | General Counsel and ... | Buy | M | 2.90 | 35,000 | 101,500 | 125,035 | 90 K to 125 K (+38.87 %) |
| Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Wolchko J Scott | President and CEO | Sell | S | 109.65 | 2,300 | 252,204 | 350,562 | 352.9 K to 350.6 K (-0.65 %) |
| Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Wolchko J Scott | President and CEO | Sell | S | 110.76 | 2,772 | 307,021 | 352,862 | 355.6 K to 352.9 K (-0.78 %) |
| Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Wolchko J Scott | President and CEO | Sell | S | 111.62 | 3,515 | 392,330 | 355,634 | 359.1 K to 355.6 K (-0.98 %) |
| Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Wolchko J Scott | President and CEO | Sell | S | 114.76 | 1,469 | 168,575 | 359,149 | 360.6 K to 359.1 K (-0.41 %) |
| Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Wolchko J Scott | President and CEO | Sell | S | 115.80 | 8,515 | 986,028 | 360,618 | 369.1 K to 360.6 K (-2.31 %) |
| Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Wolchko J Scott | President and CEO | Sell | S | 117.15 | 23,932 | 2,803,730 | 369,133 | 393.1 K to 369.1 K (-6.09 %) |
| Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Wolchko J Scott | President and CEO | Sell | S | 117.60 | 26,904 | 3,163,883 | 393,065 | 420 K to 393.1 K (-6.41 %) |
| Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Valamehr Bahram | Chief Development O ... | Sell | S | 109.65 | 871 | 95,509 | 77,727 | 78.6 K to 77.7 K (-1.11 %) |
| Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Valamehr Bahram | Chief Development O ... | Sell | S | 110.76 | 1,051 | 116,407 | 78,598 | 79.6 K to 78.6 K (-1.32 %) |
| Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Valamehr Bahram | Chief Development O ... | Sell | S | 111.62 | 1,332 | 148,673 | 79,649 | 81 K to 79.6 K (-1.64 %) |
| Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Valamehr Bahram | Chief Development O ... | Sell | S | 114.76 | 151 | 17,328 | 80,981 | 81.1 K to 81 K (-0.19 %) |
| Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Valamehr Bahram | Chief Development O ... | Sell | S | 115.80 | 872 | 100,977 | 81,132 | 82 K to 81.1 K (-1.06 %) |
| Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Valamehr Bahram | Chief Development O ... | Sell | S | 117.15 | 2,451 | 287,144 | 82,004 | 84.5 K to 82 K (-2.90 %) |
| Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Valamehr Bahram | Chief Development O ... | Sell | S | 117.60 | 2,756 | 324,103 | 84,455 | 87.2 K to 84.5 K (-3.16 %) |
| Jan 12 2021 | FATE | FATE THERAPEUTICS ... | TAHL CINDY | General Counsel and ... | Sell | S | 109.65 | 872 | 95,618 | 90,035 | 90.9 K to 90 K (-0.96 %) |
| Jan 12 2021 | FATE | FATE THERAPEUTICS ... | TAHL CINDY | General Counsel and ... | Sell | S | 110.76 | 1,050 | 116,296 | 90,907 | 92 K to 90.9 K (-1.14 %) |
| Jan 12 2021 | FATE | FATE THERAPEUTICS ... | TAHL CINDY | General Counsel and ... | Sell | S | 111.62 | 1,332 | 148,673 | 91,957 | 93.3 K to 92 K (-1.43 %) |
| Jan 12 2021 | FATE | FATE THERAPEUTICS ... | TAHL CINDY | General Counsel and ... | Sell | S | 114.76 | 151 | 17,328 | 93,289 | 93.4 K to 93.3 K (-0.16 %) |
| Jan 12 2021 | FATE | FATE THERAPEUTICS ... | TAHL CINDY | General Counsel and ... | Sell | S | 115.80 | 872 | 100,977 | 93,440 | 94.3 K to 93.4 K (-0.92 %) |
| Jan 12 2021 | FATE | FATE THERAPEUTICS ... | TAHL CINDY | General Counsel and ... | Sell | S | 117.15 | 2,451 | 287,144 | 94,312 | 96.8 K to 94.3 K (-2.53 %) |
| Jan 12 2021 | FATE | FATE THERAPEUTICS ... | TAHL CINDY | General Counsel and ... | Sell | S | 117.60 | 2,755 | 323,985 | 96,763 | 99.5 K to 96.8 K (-2.77 %) |
| Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 109.65 | 871 | 95,509 | 83,609 | 84.5 K to 83.6 K (-1.03 %) |
| Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 110.76 | 1,050 | 116,296 | 84,480 | 85.5 K to 84.5 K (-1.23 %) |
| Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 111.62 | 1,332 | 148,673 | 85,530 | 86.9 K to 85.5 K (-1.53 %) |
| Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 114.76 | 151 | 17,328 | 86,862 | 87 K to 86.9 K (-0.17 %) |
| Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 115.80 | 872 | 100,977 | 87,013 | 87.9 K to 87 K (-0.99 %) |
| Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 117.15 | 2,451 | 287,144 | 87,885 | 90.3 K to 87.9 K (-2.71 %) |
| Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 117.60 | 2,755 | 323,985 | 90,336 | 93.1 K to 90.3 K (-2.96 %) |
| Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Redmile Group, LLC | Director | Option Exercise | P | 0.00 | 257,310 | 257 | 257,310 | |
| Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Redmile Group, LLC | Director | Buy | P | 85.50 | 327,485 | 27,999,968 | 12,957,222 | 12.6 M to 13 M (+2.59 %) |